🇰🇷 South Korea Clinical Trials Database
Search 18,000+ clinical trials conducted in South Korea. Access comprehensive trial data including phases, sponsors, outcomes, and locations from CRIS & International Registries. Part of Pure Global AI's free database with 840,000+ trials worldwide.
What is the South Korea clinical trials database?
The South Korea clinical trials database contains over 18,000 clinical trials registered through CRIS (Clinical Research Information Service) and international registries. South Korea is a major hub for clinical research in Asia with advanced healthcare infrastructure.
How do I search for clinical trials in South Korea?
Enter a disease name, drug name, sponsor (like "Samsung Bioepis" or "Celltrion"), or trial ID in the search box. Results include trials conducted in South Korea from multiple registries.
What regulatory body oversees clinical trials in South Korea?
The Ministry of Food and Drug Safety (MFDS) oversees clinical trials in South Korea. Korea has a well-established regulatory framework aligned with ICH guidelines.
Is this database free to use?
Yes, this database is completely free. Pure Global AI provides free access to help researchers and companies navigate Korean clinical research.
Why is South Korea popular for clinical trials?
South Korea offers excellent healthcare infrastructure, treatment-naive patients, competitive costs, and experienced investigators. Korean data is often accepted by FDA and other regulators.
What types of trials are common in South Korea?
South Korea has strong activity in oncology, biosimilars, cell therapy, and medical devices. Korean companies like Samsung Bioepis and Celltrion are global leaders in biosimilar development.
About This Database
This database provides free access to clinical trial data from South Korea. Korea is a leading clinical trial destination in Asia with world-class hospitals and research centers. Use this tool to research the Korean market, find MFDS trial opportunities, and track drug/device development in this key Asian market.